Prognosis of BRCA-associated breast cancer: A summary of evidence

Breast Cancer Research and Treatment

Volumn 119, Issue 1, 2010, Pages 13-24

  Bordeleau, L ^a   Panchal, S ^b   Goodwin, P ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

BRCA1; BRCA2; Breast Cancer; Prognosis

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CLINICAL STUDY; COHORT ANALYSIS; GENE MUTATION; HUMAN; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 72449148140     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0566-z     Document Type: Review

References (53)

1. A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117 1130 10.1086/375033 1:CAS:528:DC%2BD3sXjslagtbg%3D 12677558 (Pubitemid 36530000)
2. SA Narod WD Foulkes 2004 BRCA1 and BRCA2: 1994 and beyond Nat Rev Cancer 4 665 676 10.1038/nrc1431 1:CAS:528:DC%2BD2cXntFCmsbk%3D 15343273 (Pubitemid 39215065)
3. F Eisinger C Nogues D Birnbaum J Jacquemier H Sobol 1998 Low frequency of lymph-node metastasis in BRCA1-associated breast cancer Lancet 351 1633 1634 10.1016/S0140-6736(05)77689-3 1:STN:280:DyaK1c3ot1SntA%3D%3D 9620724 (Pubitemid 28252186)
4. DP Atchley CT Albarracin A Lopez V Valero CI Amos AM Gonzalez-Angulo, et al. 2008 Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer J Clin Oncol 26 4282 4288 10.1200/JCO.2008.16. 6231 18779615
5. I Hedenfalk D Duggan Y Chen M Radmacher M Bittner R Simon, et al. 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 539 548 10.1056/NEJM200102223440801 1:CAS:528:DC%2BD3MXhsFGks7o%3D 11207349 (Pubitemid 32167867)
6. J Palacios E Honrado A Osorio A Cazorla D Sarrio A Barroso, et al. 2003 Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 9 3606 3614 1:CAS:528:DC%2BD3sXosVOlurc%3D 14506147
7. SR Lakhani J Jacquemier JP Sloane BA Gusterson TJ Anderson MJ van de Vijver, et al. 1998 Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1138 1145 10.1093/jnci/90.15.1138 1:CAS:528:DyaK1cXlsVOrs78%3D 9701363
8. WA Albano JA Recabaren HT Lynch AS Campbell JA Mailliard CH Organ, et al. 1982 Natural history of hereditary cancer of the breast and colon Cancer 50 360 363 10.1002/1097-0142(19820715)50:2<360::AID-CNCR2820500233>3.0.CO;2-4 1:STN:280:DyaL383gvVWqsg%3D%3D 7083143 (Pubitemid 12089401)
9. JM Hall MK Lee B Newman JE Morrow LA Anderson B Huey, et al. 1990 Linkage of early-onset familial breast cancer to chromosome 17q21 Science 250 1684 1689 10.1126/science.2270482 1:STN:280:DyaK3M7gt1GnsA%3D%3D 2270482
10. SA Narod J Feunteun HT Lynch P Watson T Conway J Lynch, et al. 1991 Familial breast-ovarian cancer locus on chromosome 17q12-q23 Lancet 338 82 83 10.1016/0140-6736(91)90076-2 1:STN:280:DyaK3M3oslChuw%3D%3D 1676470
11. JM Hall L Friedman C Guenther MK Lee JL Weber DM Black, et al. 1992 Closing in on a breast cancer gene on chromosome 17q Am J Hum Genet 50 1235 1242 1:CAS:528:DyaK38Xlt1Gks78%3D 1598904
12. DE Porter M Dixon E Smyth CM Steel 1993 Breast cancer survival in BRCA1 carriers Lancet 341 184 185 10.1016/0140-6736(93)90052-I 1:STN:280: DyaK3s7ktVCrtg%3D%3D 8093792
13. DE Porter BB Cohen MR Wallace E Smyth U Chetty JM Dixon, et al. 1994 Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21 Br J Surg 81 1512 1515 10.1002/bjs.1800811038 1:STN:280:DyaK2M7itVCjtg%3D%3D 7820489 (Pubitemid 24306008)
14. R Wooster SL Neuhausen J Mangion Y Quirk D Ford N Collins, et al. 1994 Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 265 2088 2090 10.1126/science.8091231 1:CAS:528: DyaK2cXmsFejsLY%3D 8091231
15. JN Marcus P Watson DL Page SA Narod GM Lenoir P Tonin, et al. 1996 Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage Cancer 77 697 709 10.1002/(SICI)1097-0142(19960215)77:4<697::AID- CNCR16>3.0.CO;2-W 1:STN:280:DyaK287os1ymtg%3D%3D 8616762 (Pubitemid 26055395)
16. OT Johannsson J Ranstam A Borg H Olsson 1998 Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden J Clin Oncol 16 397 404 1:STN:280:DyaK1c7ivFahsQ%3D%3D 9469321
17. HT Lynch P Watson 1998 BRCA1, pathology, and survival J Clin Oncol 16 395 396 1:STN:280:DyaK1c7ivFahsA%3D%3D 9469320
18. Y Ansquer C Gautier A Fourquet B Asselain D Stoppa-Lyonnet 1998 Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352 541 10.1016/S0140-6736(05)79248-5 1:STN:280:DyaK1cznvF2itQ%3D%3D 9716060
19. DK Gaffney RM Brohet CM Lewis JA Holden SS Buys SL Neuhausen, et al. 1998 Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations Radiother Oncol 47 129 136 10.1016/S0167-8140(98) 00023-1 1:CAS:528:DyaK1cXjt1Clurk%3D 9683359 (Pubitemid 28275921)
20. LJ Pierce M Strawderman SA Narod I Oliviotto A Eisen L Dawson, et al. 2000 Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 3360 3369 1:STN:280:DC%2BD3M%2FgvFWmtQ%3D%3D 11013276
21. LC Verhoog CT Brekelmans C Seynaeve LM van den Bosch G Dahmen AN van Geel, et al. 1998 Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 Lancet 351 316 321 10.1016/S0140-6736(97)07065- 7 1:STN:280:DyaK1czhsVOiuw%3D%3D 9652611 (Pubitemid 28052696)
22. LC Verhoog CT Brekelmans C Seynaeve G Dahmen AN van Geel CC Bartels, et al. 1999 Survival in hereditary breast cancer associated with germline mutations of BRCA2 J Clin Oncol 17 3396 3402 1:STN:280:DC%2BD3c%2FhvVamsg%3D%3D 10550133
23. N Loman O Johannsson P Bendahl N Dahl Z Einbeigi A Gerdes, et al. 2000 Prognosis and clinical presentation of BRCA2-associated breast cancer Eur J Cancer 36 1365 1373 10.1016/S0959-8049(00)00098-8 1:STN:280: DC%2BD3cvisVCjsQ%3D%3D 10899649 (Pubitemid 30421140)
24. H Eerola P Vahteristo L Sarantaus P Kyyronen S Pyrhonen C Blomqvist, et al. 2001 Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland Int J Cancer 93 368 372 10.1002/ijc.1341 1:CAS:528:DC%2BD3MXlt12gsb4%3D 11433401 (Pubitemid 32592055)
25. EL Goode AM Dunning B Kuschel CS Healey NE Day BA Ponder, et al. 2002 Effect of germ-line genetic variation on breast cancer survival in a population-based study Cancer Res 62 3052 3057 1:CAS:528:DC%2BD38XksVyru7Y%3D 12036913
26. M Robson T Gilewski B Haas D Levin P Borgen P Rajan, et al. 1998 BRCA-associated breast cancer in young women J Clin Oncol 16 1642 1649 1:STN:280:DyaK1c3ks1artw%3D%3D 9586873
27. M Robson D Levin M Federici J Satagopan F Bogolminy A Heerdt, et al. 1999 Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations J Natl Cancer Inst 91 2112 2117 10.1093/jnci/91.24. 2112 1:STN:280:DC%2BD3c%2FntFSntg%3D%3D 10601383
28. PO Chappuis L Kapusta LR Begin N Wong JS Brunet SA Narod, et al. 2000 Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer J Clin Oncol 18 4045 4052 1:CAS:528: DC%2BD3MXktFegtQ%3D%3D 11118465
29. JS Lee S Wacholder JP Struewing M McAdams D Pee LC Brody, et al. 1999 Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 91 259 263 10.1093/jnci/91.3.259 1:STN:280:DyaK1M7lsVOjug%3D%3D 10037104
30. WD Foulkes N Wong JS Brunet LR Begin JC Zhang JJ Martinez, et al. 1997 Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer Clin Cancer Res 3 2465 2469 1:STN:280: DyaK1M7htFajtA%3D%3D 9815648
31. WD Foulkes PO Chappuis N Wong JS Brunet D Vesprini F Rozen, et al. 2000 Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome Ann Oncol 11 307 313 10.1023/A:1008340723974 1:STN:280: DC%2BD3c3mvFKgtg%3D%3D 10811497 (Pubitemid 30214668)
32. D Stoppa-Lyonnet Y Ansquer H Dreyfus C Gautier M Gauthier-Villars E Bourstyn, et al. 2000 Familial invasive breast cancers: worse outcome related to BRCA1 mutations J Clin Oncol 18 4053 4059 1:CAS:528:DC%2BD3MXktFegug%3D%3D 11118466
33. P Moller A Borg DG Evans N Haites MM Reis H Vasen, et al. 2002 Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy Int J Cancer 101 555 559 10.1002/ijc.10641 1:CAS:528:DC%2BD38Xns1eqsr0%3D 12237897
34. U Hamann HP Sinn 2000 Survival and tumor characteristics of German hereditary breast cancer patients Breast Cancer Res Treat 59 185 192 10.1023/A:1006350518190 1:STN:280:DC%2BD3c3nsFSmtw%3D%3D 10817354 (Pubitemid 30216142)
35. A Veronesi GC De MD Magri D Lombardi M Zanetti C Scuderi, et al. 2005 Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases BMC Cancer 5 70 10.1186/1471-2407-5-70 15996267 (Pubitemid 41461061)
36. V Bonadona S Dussart-Moser N Voirin OM Sinilnikova H Mignotte P Mathevet, et al. 2007 Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review Breast Cancer Res Treat 101 233 245 10.1007/s10549-006-9288-7 1:CAS:528:DC%2BD2sXkslensA%3D%3D 17061047 (Pubitemid 46115430)
37. B Vinodkumar V Syamala EK Abraham R Balakrishnan R Ankathil 2007 Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India J Exp Clin Cancer Res 26 329 336 1:CAS:528: DC%2BD2sXhtlSlur7N 17987791
38. ME Robson PO Chappuis J Satagopan N Wong J Boyd JR Goffin, et al. 2004 A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 R8 R17 10.1186/bcr658 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D 14680495
39. G Rennert S Bisland-Naggan O Barnett-Griness N Bar-Joseph S Zhang HS Rennert, et al. 2007 Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 115 123 10.1056/NEJMoa070608 1:CAS:528:DC%2BD2sXns12qsrk%3D 17625123 (Pubitemid 47057729)
40. PJ Goodwin KA Phillips DW West 2007 Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 1555 10.1056/NEJMc072301 1:CAS:528:DC%2BD2sXhtFKmu77E 17928608
41. DH Roukos 2007 Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 1555 1556 10.1056/NEJMc072301 1:CAS:528: DC%2BD2sXhtFKmu77F 17933033
42. CT Brekelmans C Seynaeve M Menke-Pluymers HT Bruggenwirth MM Tilanus-Linthorst CC Bartels, et al. 2006 Survival and prognostic factors in BRCA1-associated breast cancer Ann Oncol 17 391 400 10.1093/annonc/mdj095 1:STN:280:DC%2BD287ht1OksQ%3D%3D 16322115 (Pubitemid 43329574)
43. CT Brekelmans MM Tilanus-Linthorst C Seynaeve OA vd MB Menke-Pluymers CC Bartels, et al. 2007 Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, B Eur J Cancer 43 867 876 10.1016/j.ejca.2006.12.009 1:CAS:528:DC%2BD2sXisleitLw%3D 17307353 (Pubitemid 46366688)
44. M Kriege C Seynaeve H Meijers-Heijboer JM Collee MB Menke-Pluymers CC Bartels, et al. 2008 Distant disease-free interval, site of first relapse and post-relapse survival in B Breast Cancer Res Treat 111 303 311 10.1007/s10549-007-9781-7 17952592
45. P Moller DG Evans MM Reis H Gregory E Anderson L Maehle, et al. 2007 Surveillance for familial breast cancer: differences in outcome according to BRCA mutation status Int J Cancer 121 1017 1020 10.1002/ijc.22789 1:CAS:528:DC%2BD2sXhtFGhu7vI 17471561
46. I Soerjomataram MW Louwman JG Ribot JA Roukema JW Coebergh 2008 An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Res Treat 107 309 330 10.1007/s10549-007-9556-1 1:CAS:528: DC%2BD1cXht1Sgtrw%3D 17377838 (Pubitemid 351172108)
47. PL Mai N Chatterjee P Hartge M Tucker L Brody JP Struewing, et al. 2009 Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma PLoS One 4 e4812 10.1371/journal.pone.0004812 19277124
48. BG Haffty E Harrold AJ Khan P Pathare TE Smith BC Turner, et al. 2002 Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 1471 1477 10.1016/S0140-6736(02)08434-9 11988246 (Pubitemid 34457765)
49. YM Kirova D Stoppa-Lyonnet A Savignoni B Sigal-Zafrani N Fabre A Fourquet 2005 Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Eur J Cancer 41 2304 2311 10.1016/j.ejca.2005.02.037 16140006 (Pubitemid 41415607)
50. LJ Pierce AM Levin TR Rebbeck MA Ben-David E Friedman LJ Solin, et al. 2006 Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 2437 2443 10.1200/JCO.2005.02.7888 16636335 (Pubitemid 46630619)
51. SA Narod JS Brunet P Ghadirian M Robson K Heimdal SL Neuhausen, et al. 2000 Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group Lancet 356 1876 1881 10.1016/S0140-6736(00)03258-X 1:CAS:528: DC%2BD3cXovFWjsL8%3D 11130383
52. K Metcalfe HT Lynch P Ghadirian N Tung I Olivotto E Warner, et al. 2004 Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2328 2335 10.1200/JCO.2004.04.033 1:CAS:528:DC%2BD2cXpsVWltbs%3D 15197194 (Pubitemid 41115389)
53. TC van Sprundel MK Schmidt MA Rookus R Brohet CJ van Asperen EJ Rutgers, et al. 2005 Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers Br J Cancer 93 287 292 10.1038/sj.bjc.6602703 16052221 (Pubitemid 43080030)